Zurich Cantonal Bank’s Opus Genetics IRD Stock Holding History

Zurich Cantonal Bank’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-724	Closed	-$18K	–	2629
2019 Q1	$18K	Hold	724	–	–	﹤0.01%	2444
2018 Q4	$32K	Hold	724	–	–	﹤0.01%	2276
2018 Q3	$62K	Hold	724	–	–	﹤0.01%	2023
2018 Q2	$49K	Hold	724	–	–	﹤0.01%	2145
2018 Q1	$52K	Sell	724 -300	-29%	-$27.2K	﹤0.01%	2050
2017 Q4	$99K	Hold	1,024	–	–	﹤0.01%	1575
2017 Q3	$119K	Buy	+1,024	New	+$110K	﹤0.01%	1288

Other funds holding IRD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Zurich Cantonal Bank's IRD Position: Q2 2019 in Review

Zurich Cantonal Bank sold out of Opus Genetics (IRD) in Q2 2019, closing a stake of 724 shares — an estimated $18K sold.

Zurich Cantonal Bank first reported a position in IRD in Q3 2017 and held it in 7 quarters. The position peaked at $119K in Q3 2017. 16 funds tracked by Wall St. Rank hold IRD as of Q2 2019.

Zurich Cantonal Bank reported no remaining Opus Genetics position as of Q2 2019 after selling out during the quarter.
Zurich Cantonal Bank sold 724 Opus Genetics shares in Q2 2019, an estimated $18K.
Zurich Cantonal Bank first reported a position in Opus Genetics in Q3 2017 and held it in 7 quarters.
Zurich Cantonal Bank's Opus Genetics position peaked at $119K in Q3 2017.
16 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2019.

Based on Zurich Cantonal Bank's 13F filing for Q2 2019, filed 30 Jul 2019.